Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients
Year: 2004
Type: article
DOI: 10.1093/ndt/gfh106
Authors: R. Brunkhorst, J. Bommer, J. Braun, M. Haag-Weber, C. Gill, J. Wagner, T. Wagener
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2122598472
